KVT — Krynica Vitamin SA Income Statement
0.000.00%
- PLN136.61m
- PLN189.39m
- PLN359.23m
- 71
- 47
- 19
- 40
Annual income statement for Krynica Vitamin SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 297 | 446 | 395 | 377 | 359 |
Cost of Revenue | |||||
Gross Profit | 38.3 | 120 | 58.5 | 66.3 | 51.8 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 286 | 372 | 375 | 360 | 362 |
Operating Profit | 10.6 | 74.4 | 20.5 | 16.7 | -3.04 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.26 | 71.5 | 21 | 14.1 | -6.74 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.06 | 56.9 | 15.6 | 13.1 | -6.68 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.06 | 56.9 | 15.6 | 13.1 | -6.68 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.06 | 56.9 | 15.6 | 13.1 | -6.68 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.541 | 4.75 | 1.45 | 1.38 | 0.077 |
Dividends per Share |